2005
DOI: 10.1186/1477-7819-3-1
|View full text |Cite
|
Sign up to set email alerts
|

Untitled

Abstract: Background: Core biopsy is a method of choice for the triple assessment of breast disease as it can reliably distinguish between benign and malignant tumours, between in-situ and invasive cancers and can be useful to assess oestrogen receptor status. This study was carried out to assess the reliability of core biopsy in predicting the grade and type of cancer accurately as obtaining this information can influence initial therapeutic decisions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(12 citation statements)
references
References 25 publications
(16 reference statements)
0
12
0
Order By: Relevance
“…It has been estimated globally that each year ~1-2 million people die from HBV related complications such as chronic hepatitis, cirrhosis hepatocellular carcinoma (HCC) [2-8]. HBV is endemic in the Pakistani population with a rate of 3% HBV carriers in the country.…”
Section: Introductionmentioning
confidence: 99%
“…It has been estimated globally that each year ~1-2 million people die from HBV related complications such as chronic hepatitis, cirrhosis hepatocellular carcinoma (HCC) [2-8]. HBV is endemic in the Pakistani population with a rate of 3% HBV carriers in the country.…”
Section: Introductionmentioning
confidence: 99%
“…Despite reports suggesting that chronic carriers of HBV/HDV have a 3-fold increased risk of HCC, and develop HCC approximately 14 years earlier than carriers of HBV only, there is no consensus opinion on the relationship between HDV infection and liver cancer. The molecular basis of HDV pathogenesis is poorly understood, and the role of HDV in HCC induction/development has yet to be elucidated (1, 56, 1013). …”
mentioning
confidence: 99%
“…1). Finally, 22 reports were left in this meta-analysis, including one of oral cavity, [32] 1 of lung, [33] 1 of lymphocyte, [34] 2 of kidney, [35,36] 2 of bladder, [37,38] 2 of skin, [39,40] 2 of colon, [41,42] 3 of ovary, [4345] 3 of liver [4648] and 5 of breast. [4953] In total, 2843 patients were enrolled in this meta-analysis, with 1517 cases in the MT negative/low group and 1326 cases in the MT high group (Table 1).…”
Section: Resultsmentioning
confidence: 99%
“…Thirdly, the expression of MTs was dramatically higher at night than in the day, [60,61] which meant unavoidable sampling errors. Fourthly, too few sample size in some studies [35,36,44,53] might lead a significant statistical type I error. Fifthly, all the HRs referred in the meta-analysis were calculated from survival curves, which might be less reliable than the actual HRs.…”
Section: Discussionmentioning
confidence: 99%